The global market for artificial heart and ventricular assist devices (VADs) has witnessed significant growth lately, driven by technological advancements and strategic initiatives by leading companies. Prominent manufacturers such as Abbott Laboratories and Abiomed carve out a substantial market share, mainly due to a diversified product strategy and strategic expansions. This article provides an overview of the key players, recent mergers and market trends, focusing on the products strategy of those companies throughout the last decade, considering the evolving environment of this critical segment of the medical devices industry. The technique used for product strategy assessment was the strategic positioning map. It was taken into consideration the diversity of the product range, the price, the promotion as well as the additional services provided. While some companies focus on a narrowing their range of medical products with a particular emphasis on temporary artificial heart devices and hemodynamic support, others offer a broader and more diverse range of medical devices, including ventricular assist devices, services, drugs, and nutritional supplements that allow them a consolidated position on the global market.